Habib J. Dable, CEO and President at ACCELERON PHARMA INC (XLRN), sold 176,840 shares at $125.15 ($22.4M) on 2021-07-01, disclosed to the SEC on 2021-07-02.
Open-market sale of $22.4M XLRN by CEO and President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $125.15 | 11,845 | $1.5M | 6.6% |
| 2 | $125.15 | 11,845 | $1.5M | 6.6% |
| 3 | $125.81 | 9,194 | $1.2M | 5.2% |
| 4 | $125.81 | 9,194 | $1.2M | 5.2% |
| 5 | $126.85 | 23,160 | $2.9M | 13.1% |
| 6 | $127.89 | 4,560 |
| $583K |
| 2.6% |
| 7 | $127.89 | 4,560 | $583K | 2.6% |
| 8 | $128.82 | 9,055 | $1.2M | 5.2% |
| 9 | $128.82 | 9,055 | $1.2M | 5.2% |
| 10 | $126.69 | 29,140 | $3.7M | 16.5% |
| 11 | $126.69 | 29,140 | $3.7M | 16.5% |
| 12 | $127.51 | 11,458 | $1.5M | 6.5% |
| 13 | $127.51 | 11,458 | $1.5M | 6.5% |
| 14 | $128.21 | 1,588 | $204K | 0.9% |
| 15 | $128.21 | 1,588 | $204K | 0.9% |
| Total | $126.83 avg | 176,840 | $22.4M | 100% |
| Filing → |
| XLRN | SELL | 2020-01-03 | $377K | — | Filing → |
| XLRN | SELL | 2019-09-10 | $493K | — | Filing → |
| XLRN | SELL | 2019-04-11 | $654K | — | Filing → |